Jaguar Health

Update in progress

JAGX (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Jaguar Health, Inc. is a commercial-stage pharmaceutical company developing plant-based prescription medicines for gastrointestinal distress in people and animals. It has Animal Health and Human Health segments, with products for companion and production animals as well as human patients. Key products include Mytesi for non-infectious diarrhea in adults with HIV/AIDS and Canalevia-CA1 for chemotherapy-induced diarrhea in dogs. Headquartered in San Francisco.

Company score

Sentiment: 0.50; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.44; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.17; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.17; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.33; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive